ID

34155

Descrizione

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01303419

collegamento

https://clinicaltrials.gov/show/NCT01303419

Keywords

  1. 14/01/19 14/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

14 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT01303419

Eligibility Breast Cancer NCT01303419

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
woman 21 years of age or older
Descrizione

ID.1

Tipo di dati

boolean

the subject is able and willing to comply with study procedures and signed and dated informed consent is obtained.
Descrizione

ID.2

Tipo di dati

boolean

newly diagnosed with breast cancer (dcis or invasive) identified through core biopsy or fine-needle aspiration (fna) within last 30 days.
Descrizione

ID.3

Tipo di dati

boolean

will have or have had a bilateral ce-bmri performed within 30 days after the new breast cancer diagnosis.
Descrizione

ID.4

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
woman who has already had a lumpectomy for the index lesion.
Descrizione

ID.5

Tipo di dati

boolean

woman undergoing neoadjuvant chemotherapy treatment, hormone treatment or radiation therapy.
Descrizione

ID.6

Tipo di dati

boolean

woman who is pregnant or who believe she may be pregnant.
Descrizione

ID.7

Tipo di dati

boolean

woman who has breast implant.
Descrizione

ID.8

Tipo di dati

boolean

woman who has a contraindication to the intravenous use of iodinated or gadolinium-chelated contrast agent (e.g., allergy to either agent or severely impaired renal function).
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Breast Cancer NCT01303419

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
woman 21 years of age or older
boolean
ID.2
Item
the subject is able and willing to comply with study procedures and signed and dated informed consent is obtained.
boolean
ID.3
Item
newly diagnosed with breast cancer (dcis or invasive) identified through core biopsy or fine-needle aspiration (fna) within last 30 days.
boolean
ID.4
Item
will have or have had a bilateral ce-bmri performed within 30 days after the new breast cancer diagnosis.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
woman who has already had a lumpectomy for the index lesion.
boolean
ID.6
Item
woman undergoing neoadjuvant chemotherapy treatment, hormone treatment or radiation therapy.
boolean
ID.7
Item
woman who is pregnant or who believe she may be pregnant.
boolean
ID.8
Item
woman who has breast implant.
boolean
ID.9
Item
woman who has a contraindication to the intravenous use of iodinated or gadolinium-chelated contrast agent (e.g., allergy to either agent or severely impaired renal function).
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial